Bristol-Myers Sues To Block Rival's Generic Leukemia Drug
Bristol-Myers Squibb Co. filed a patent infringement suit Monday in New Jersey federal court, seeking to block Accord Healthcare Inc. from producing a generic version of Bristol-Myers' leukemia drug....To view the full article, register now.
Already a subscriber? Click here to view full article